Lepu Medical Technology (Beijing) (300003.SZ) Earnings Analysis

Lepu Medical Technology (Beijing) (300003.SZ) next reports earnings on 2026-08-22, consensus EPS 0.1443 CNY. Last quarter (2026-04-23) it missed with EPS -0.01033 CNY vs 0.02466 CNY est (-141.9%). It has beaten estimates in 3/7 recent quarters (43%). Trailing P/E 28.28.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 300003.SZ next report earnings?

Next earnings date2026-08-22
Consensus EPS estimate0.1443 CNY
Revenue estimate1.69B

300003.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-23-0.01033 CNY0.02466 CNY-141.9%Miss
2026-04-170.13 CNY0.1711 CNY-24%Miss
2025-10-240.1579 CNY0.1499 CNY+5.3%Beat
2025-08-230.17 CNY0.1231 CNY+38.1%Beat
2025-04-180.21 CNY0.14 CNY+50%Beat
2024-10-250.06 CNY0.17 CNY-64.7%Miss
2024-08-230.12 CNY0.27 CNY-55.6%Miss

Beat rate: 3/7 (43%) over reported quarters with consensus data.

300003.SZ valuation and analyst view

Trailing P/E28.28
Trailing EPS0.4504 CNY
Price / book1.42
Dividend yield2.56%
Market cap23.78B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Lepu Medical Technology (Beijing) (300003.SZ)'s next earnings date?

Lepu Medical Technology (Beijing) is next scheduled to report on 2026-08-22, with a consensus EPS estimate of 0.1443 CNY and revenue estimate of 1.69B.

Did 300003.SZ beat earnings last quarter?

In its 2026-04-23 report, 300003.SZ posted EPS of -0.01033 CNY versus a 0.02466 CNY estimate — a miss of 141.9%.

What is 300003.SZ's earnings track record?

Over the last 7 reported quarters with consensus data, 300003.SZ beat estimates 3 times (43%).

What is 300003.SZ's current P/E ratio and EPS?

300003.SZ trades at a trailing P/E of 28.28 on trailing EPS of 0.45040130892982994 CNY.

What do analysts rate 300003.SZ?

300003.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.